Opioid Induced Constipation Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 69 pages | ID: OBCC12E88F3EEN
Market Monitor Global

Abstracts

There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over the recent past, but the continuous approval rate of highly targeted drugs is expected to provide a strong push to this market’s growth rate.

This report contains market size and forecasts of Opioid Induced Constipation Treatment in Global, including the following market information:

Global Opioid Induced Constipation Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Opioid Induced Constipation Treatment market was valued at 1010.3 million in 2021 and is projected to reach US$ 3019.3 million by 2028, at a CAGR of 16.9% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Opioid Induced Constipation Treatment include GlaxoSmithKline, AstraZeneca, Pfizer, S.L.A. Pharma, AIKO Biotechnology, Cubist Pharmaceuticals, Salix Pharmaceuticals and Takeda Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Opioid Induced Constipation Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Opioid Induced Constipation Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Opioid Induced Constipation Treatment Market Segment Percentages, by Type, 2021 (%)

• Oral
• Parenteral (Subcutaneous Injection)

Global Opioid Induced Constipation Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Opioid Induced Constipation Treatment Market Segment Percentages, by Application, 2021 (%)

• Drug Store
• Hospital Pharmacies

Global Opioid Induced Constipation Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Opioid Induced Constipation Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Opioid Induced Constipation Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Opioid Induced Constipation Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline
• AstraZeneca
• Pfizer
• S.L.A. Pharma
• AIKO Biotechnology
• Cubist Pharmaceuticals
• Salix Pharmaceuticals
• Takeda Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Opioid Induced Constipation Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Opioid Induced Constipation Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL OPIOID INDUCED CONSTIPATION TREATMENT OVERALL MARKET SIZE

2.1 Global Opioid Induced Constipation Treatment Market Size: 2021 VS 2028
2.2 Global Opioid Induced Constipation Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Opioid Induced Constipation Treatment Players in Global Market
3.2 Top Global Opioid Induced Constipation Treatment Companies Ranked by Revenue
3.3 Global Opioid Induced Constipation Treatment Revenue by Companies
3.4 Top 3 and Top 5 Opioid Induced Constipation Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Opioid Induced Constipation Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Opioid Induced Constipation Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Opioid Induced Constipation Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Opioid Induced Constipation Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Opioid Induced Constipation Treatment Market Size Markets, 2021 & 2028
  4.1.2 Oral
  4.1.3 Parenteral (Subcutaneous Injection)
4.2 By Type - Global Opioid Induced Constipation Treatment Revenue & Forecasts
  4.2.1 By Type - Global Opioid Induced Constipation Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Opioid Induced Constipation Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Opioid Induced Constipation Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Opioid Induced Constipation Treatment Market Size, 2021 & 2028
  5.1.2 Drug Store
  5.1.3 Hospital Pharmacies
5.2 By Application - Global Opioid Induced Constipation Treatment Revenue & Forecasts
  5.2.1 By Application - Global Opioid Induced Constipation Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Opioid Induced Constipation Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Opioid Induced Constipation Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Opioid Induced Constipation Treatment Market Size, 2021 & 2028
6.2 By Region - Global Opioid Induced Constipation Treatment Revenue & Forecasts
  6.2.1 By Region - Global Opioid Induced Constipation Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Opioid Induced Constipation Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Opioid Induced Constipation Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Opioid Induced Constipation Treatment Revenue, 2017-2028
  6.3.2 US Opioid Induced Constipation Treatment Market Size, 2017-2028
  6.3.3 Canada Opioid Induced Constipation Treatment Market Size, 2017-2028
  6.3.4 Mexico Opioid Induced Constipation Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Opioid Induced Constipation Treatment Revenue, 2017-2028
  6.4.2 Germany Opioid Induced Constipation Treatment Market Size, 2017-2028
  6.4.3 France Opioid Induced Constipation Treatment Market Size, 2017-2028
  6.4.4 U.K. Opioid Induced Constipation Treatment Market Size, 2017-2028
  6.4.5 Italy Opioid Induced Constipation Treatment Market Size, 2017-2028
  6.4.6 Russia Opioid Induced Constipation Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Opioid Induced Constipation Treatment Market Size, 2017-2028
  6.4.8 Benelux Opioid Induced Constipation Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Opioid Induced Constipation Treatment Revenue, 2017-2028
  6.5.2 China Opioid Induced Constipation Treatment Market Size, 2017-2028
  6.5.3 Japan Opioid Induced Constipation Treatment Market Size, 2017-2028
  6.5.4 South Korea Opioid Induced Constipation Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Opioid Induced Constipation Treatment Market Size, 2017-2028
  6.5.6 India Opioid Induced Constipation Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Opioid Induced Constipation Treatment Revenue, 2017-2028
  6.6.2 Brazil Opioid Induced Constipation Treatment Market Size, 2017-2028
  6.6.3 Argentina Opioid Induced Constipation Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Opioid Induced Constipation Treatment Revenue, 2017-2028
  6.7.2 Turkey Opioid Induced Constipation Treatment Market Size, 2017-2028
  6.7.3 Israel Opioid Induced Constipation Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Opioid Induced Constipation Treatment Market Size, 2017-2028
  6.7.5 UAE Opioid Induced Constipation Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GlaxoSmithKline
  7.1.1 GlaxoSmithKline Corporate Summary
  7.1.2 GlaxoSmithKline Business Overview
  7.1.3 GlaxoSmithKline Opioid Induced Constipation Treatment Major Product Offerings
  7.1.4 GlaxoSmithKline Opioid Induced Constipation Treatment Revenue in Global Market (2017-2022)
  7.1.5 GlaxoSmithKline Key News
7.2 AstraZeneca
  7.2.1 AstraZeneca Corporate Summary
  7.2.2 AstraZeneca Business Overview
  7.2.3 AstraZeneca Opioid Induced Constipation Treatment Major Product Offerings
  7.2.4 AstraZeneca Opioid Induced Constipation Treatment Revenue in Global Market (2017-2022)
  7.2.5 AstraZeneca Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Opioid Induced Constipation Treatment Major Product Offerings
  7.3.4 Pfizer Opioid Induced Constipation Treatment Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 S.L.A. Pharma
  7.4.1 S.L.A. Pharma Corporate Summary
  7.4.2 S.L.A. Pharma Business Overview
  7.4.3 S.L.A. Pharma Opioid Induced Constipation Treatment Major Product Offerings
  7.4.4 S.L.A. Pharma Opioid Induced Constipation Treatment Revenue in Global Market (2017-2022)
  7.4.5 S.L.A. Pharma Key News
7.5 AIKO Biotechnology
  7.5.1 AIKO Biotechnology Corporate Summary
  7.5.2 AIKO Biotechnology Business Overview
  7.5.3 AIKO Biotechnology Opioid Induced Constipation Treatment Major Product Offerings
  7.5.4 AIKO Biotechnology Opioid Induced Constipation Treatment Revenue in Global Market (2017-2022)
  7.5.5 AIKO Biotechnology Key News
7.6 Cubist Pharmaceuticals
  7.6.1 Cubist Pharmaceuticals Corporate Summary
  7.6.2 Cubist Pharmaceuticals Business Overview
  7.6.3 Cubist Pharmaceuticals Opioid Induced Constipation Treatment Major Product Offerings
  7.6.4 Cubist Pharmaceuticals Opioid Induced Constipation Treatment Revenue in Global Market (2017-2022)
  7.6.5 Cubist Pharmaceuticals Key News
7.7 Salix Pharmaceuticals
  7.7.1 Salix Pharmaceuticals Corporate Summary
  7.7.2 Salix Pharmaceuticals Business Overview
  7.7.3 Salix Pharmaceuticals Opioid Induced Constipation Treatment Major Product Offerings
  7.7.4 Salix Pharmaceuticals Opioid Induced Constipation Treatment Revenue in Global Market (2017-2022)
  7.7.5 Salix Pharmaceuticals Key News
7.8 Takeda Pharmaceutical
  7.8.1 Takeda Pharmaceutical Corporate Summary
  7.8.2 Takeda Pharmaceutical Business Overview
  7.8.3 Takeda Pharmaceutical Opioid Induced Constipation Treatment Major Product Offerings
  7.8.4 Takeda Pharmaceutical Opioid Induced Constipation Treatment Revenue in Global Market (2017-2022)
  7.8.5 Takeda Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Opioid Induced Constipation Treatment Market Opportunities & Trends in Global Market
Table 2. Opioid Induced Constipation Treatment Market Drivers in Global Market
Table 3. Opioid Induced Constipation Treatment Market Restraints in Global Market
Table 4. Key Players of Opioid Induced Constipation Treatment in Global Market
Table 5. Top Opioid Induced Constipation Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Opioid Induced Constipation Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Opioid Induced Constipation Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Opioid Induced Constipation Treatment Product Type
Table 9. List of Global Tier 1 Opioid Induced Constipation Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Opioid Induced Constipation Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Opioid Induced Constipation Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Opioid Induced Constipation Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Opioid Induced Constipation Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Opioid Induced Constipation Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Opioid Induced Constipation Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Opioid Induced Constipation Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Opioid Induced Constipation Treatment Product Offerings
Table 32. GlaxoSmithKline Opioid Induced Constipation Treatment Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Opioid Induced Constipation Treatment Product Offerings
Table 35. AstraZeneca Opioid Induced Constipation Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Opioid Induced Constipation Treatment Product Offerings
Table 38. Pfizer Opioid Induced Constipation Treatment Revenue (US$, Mn), (2017-2022)
Table 39. S.L.A. Pharma Corporate Summary
Table 40. S.L.A. Pharma Opioid Induced Constipation Treatment Product Offerings
Table 41. S.L.A. Pharma Opioid Induced Constipation Treatment Revenue (US$, Mn), (2017-2022)
Table 42. AIKO Biotechnology Corporate Summary
Table 43. AIKO Biotechnology Opioid Induced Constipation Treatment Product Offerings
Table 44. AIKO Biotechnology Opioid Induced Constipation Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Cubist Pharmaceuticals Corporate Summary
Table 46. Cubist Pharmaceuticals Opioid Induced Constipation Treatment Product Offerings
Table 47. Cubist Pharmaceuticals Opioid Induced Constipation Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Salix Pharmaceuticals Corporate Summary
Table 49. Salix Pharmaceuticals Opioid Induced Constipation Treatment Product Offerings
Table 50. Salix Pharmaceuticals Opioid Induced Constipation Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Takeda Pharmaceutical Corporate Summary
Table 52. Takeda Pharmaceutical Opioid Induced Constipation Treatment Product Offerings
Table 53. Takeda Pharmaceutical Opioid Induced Constipation Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Opioid Induced Constipation Treatment Segment by Type in 2021
Figure 2. Opioid Induced Constipation Treatment Segment by Application in 2021
Figure 3. Global Opioid Induced Constipation Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Opioid Induced Constipation Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Opioid Induced Constipation Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Opioid Induced Constipation Treatment Revenue in 2021
Figure 8. By Type - Global Opioid Induced Constipation Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Opioid Induced Constipation Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Opioid Induced Constipation Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Opioid Induced Constipation Treatment Revenue Market Share, 2017-2028
Figure 12. US Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Opioid Induced Constipation Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Opioid Induced Constipation Treatment Revenue Market Share, 2017-2028
Figure 24. China Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Opioid Induced Constipation Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Opioid Induced Constipation Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Opioid Induced Constipation Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Opioid Induced Constipation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Opioid Induced Constipation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Opioid Induced Constipation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. S.L.A. Pharma Opioid Induced Constipation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AIKO Biotechnology Opioid Induced Constipation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cubist Pharmaceuticals Opioid Induced Constipation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Salix Pharmaceuticals Opioid Induced Constipation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Takeda Pharmaceutical Opioid Induced Constipation Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)